[1]Peng DX, Luo M, Qiu LW, et al. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer [J]. Oncol Rep, 2012, 27(4):1238-1244.
[2]Leite KR, Tomiyama A, Reis ST, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer [J]. J Urol, 2011, 185(3):1118-1122.
[3]Di J, Bai ShL, Zhang LZh, et al. Expression of Polo-like kinase 1 during the differentiation of cardiomyocytes in rats [J]. Acta Anatomica Sinica, 2008, 39(4):578-581. (in Chinese)
邸菁, 柏树令, 张凌志, 等. Polo 样激酶1 在大鼠心肌细胞分化过程中的表达[J]. 解剖学报, 2008, 39(4):578-581.
[4]Li BH, Zhou JS, Ye F, et al. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein [J]. Eur J Cancer, 2011, 47(14): 2166-2174.
[5]Ng WL, Yan D, Zhang X, et al. Over-expression of miR-100 is responsible for the low- expression of ATM in the human glioma cell line: M059J [J]. DNA Repair, 2010, 9(11): 1170-1175.
[6]de Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features[J]. Leuk Res, 2012, 36(3):29329-29338.
[7]Lera RF, Burkard ME.High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells[J]. J Biol Chem, 2012, 287(51): 42812-42825.
[8]Pellegrino R, Calvisi DF, Ladu S, et al. Oncogenic and tumor suppressive roles of Polo-like kinases in human hepatocellular carcinoma [J]. Hepatology, 2010, 51(3): 857-868.[9]He Z, Wu J, Dang H, et al. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of survivin expression [J]. Cancer Lett, 2011, 303(2):92-98.
[10]Han DP, Zhu QL, Cui JT, et al. Polo-like kinase 1 is overex-pressed in colorectal cancer and participates in the migration and in-vasion of colorectal cancer cells [J]. Med Sci Monit, 2012, 18(6):237-246.
[11]Reagan-Shaw S, Ahmad N. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer [J]. FASEB J, 2005, 19(6): 611-613.
[12]de Oliveira JC, Brassesco MS, Pezuk JA, et al. In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells [J]. J Drugs Dermatol, 2012, 11(5):5875-5892. |